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Understanding the fiber-type specification and
metabolic switch in skeletal muscle provides in-
sights into energy metabolism in physiology and
diseases. Here, we show that miR-182 is highly ex-
pressed in fast-twitch muscle and negatively corre-
lates with blood glucose level. miR-182 knockout
mice display muscle loss, fast-to-slow fiber-type
switching, and impaired glucosemetabolism.Mech-
anistic studies reveal that miR-182 modulates
glucose utilization in muscle by targeting FoxO1
and PDK4, which control fuel selection via the pyru-
vate dehydrogenase complex (PDHC). Short-term
high-fat diet (HFD) feeding reduces muscle miR-
182 levels by tumor necrosis factor a (TNFa), which
contributes to the upregulation of FoxO1/PDK4.
Restoration of miR-182 expression in HFD-fed
mice induces a faster muscle phenotype, decreases
muscle FoxO1/PDK4 levels, and improves glucose
metabolism. Together, our work establishes miR-
182 as a critical regulator that confers robust and
precise controls on fuel usage and glucose homeo-
stasis. Our study suggests that a metabolic shift
toward a faster and more glycolytic phenotype is
beneficial for glucose control.This is an open access article under the CC BY-NINTRODUCTION
Skeletal muscles are composed of different types of fibers
exhibiting distinct contractile andmetabolic properties. Myofiber
types are characterized by different myosin heavy chain (MyHC)
subtypes. For example, type I (slow oxidative) fibers express
slowMyHC (MyHC I), whereas type II (fast glycolitic/oxidative) fi-
bers express fast MyHC (MyHC IIa, IIx/d, and IIb) (Schiaffino and
Reggiani, 1996). It has been widely accepted that type I fibers
possess higher oxidative capacity compared to type II fibers
and that enhancing oxidative metabolism has beneficial meta-
bolic effects. However, a growing body of evidence suggests
that an increase in glycolytic metabolism also has the capacity
to improve glucose homeostasis (Gordon et al., 2009; Izumiya
et al., 2008; LeBrasseur et al., 2011; Meng et al., 2013). It is still
not clear whether obesity or diabetes is a cause or consequence
of the transition from oxidative to glycolytic metabolism in mus-
cle (Patti et al., 2003; Petersen et al., 2003). Therefore, under-
standing the molecular basis for fiber-type specification and
metabolic switch in skeletal muscle may not only have implica-
tions for obesity and diabetes but also help us to develop new
strategies to improve metabolism in disease.
Metabolic flexibility is the capacity for the organism to adapt
fuel oxidation to fuel availability (Galgani et al., 2008). When the
glucose level is low during fasting or after exercise, the
major energy source for skeletal muscle is switched from carbo-
hydrate to other energy sources, such as fatty acids or amino
acids, to preserve glycogen storage and glucose levels forCell Reports 16, 757–768, July 19, 2016 ª 2016 The Author(s). 757
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
glucose-dependent tissues (Cahill et al., 1966). Since metabolic
flexibility is impaired in the muscle of insulin-resistant patients
(Galgani et al., 2008; Kelley and Mandarino, 2000), the molecular
mechanisms underlying the fuel usage have received increasing
attention. The fuel selection occurs at the level of the pyruvate
dehydrogenase complex (PDHC), which catalyzes pyruvate to
form acetyl-CoA (coenzyme A) and links glycolysis to the tricar-
boxylic acid (TCA) cycle and ATP production (Zhang et al.,
2014b). The PDHC activity largely depends on its phosphoryla-
tion status, which is under the control of pyruvate dehydroge-
nase kinase (PDK) isoenzymes. The isoform PDK4 is highly
expressed in skeletal muscle and upregulated upon starvation
and under pathological conditions associated with the switch
from the utilization of glucose to fatty acids as an energy source,
such as high-fat diet (HFD)-induced insulin resistance and type 2
diabetes (T2D) (Rinnankoski-Tuikka et al., 2012). In addition, the
mRNA expression level of PDK4 is also regulated by the tran-
scriptional factor, forkhead box O1 (FoxO1) (Furuyama et al.,
2003). The regulatory role of the FoxO1/PDK4/PDHC axis in
metabolic flexibility has been suggested.
MicroRNAs (miRNAs) are small non-coding RNAs that regu-
late target gene expression post-transcriptionally. Recently, it
has been shown that miRNAs modulate insulin action in multiple
metabolic organs, including liver, adipose tissue, and muscle.
Whether miRNAs control whole-body glucose homeostasis by
targeting key genes involved in fuel selection in muscle is largely
unknown. miR-182 has been previously reported as a potential
signature miRNA that distinguished patients with impaired fast-
ing glucose (IFG) and T2D.miR-182 is downregulated in the skel-
etal muscle of diabetic rats and obese mice (Karolina et al.,
2011). However, whether the alteration of miR-182 expression
is an early event during the development of metabolic disease
is not clear. More importantly, the role of skeletal muscle miR-
182 in glucose homeostasis and pathogenesis of T2D and the
upstream stimuli that control the miR-182 expression remain
unknown.
Here, we identified miR-182 as a miRNA enriched in fast-
twitch muscles. Mice lacking miR-182 displayed a fast-to-slow
muscle fiber conversion and abnormal glucose metabolism.
The regulation of miR-182 on the FoxO1/PDK4/PDHC axis via
direct targeting of both FoxO1 and PDK4 was established.
Further studies revealed that miR-182 could affect the phos-
phorylation status and enzyme activity of PDHC in muscle,
thereby modulating glucose utilization, while restoration of
miR-182 expression in the muscle of diabetic mice improved
glucose metabolism. Together, our data demonstrated that
miR-182 plays an important role in muscle fiber-type switch
and fuel selection and suggest miR-182 as a therapeutic target
for metabolic diseases.
RESULTS
miR-182 Is Enriched in Fast-Twitch Muscles
To identify key miRNAs involved in metabolic regulation and
myofiber specification of fast-twitch glycolytic and slow-twitch
oxidative muscle, we compared the miRNA expression profiles
between the glycolytic, fast (type II) fiber-enriched gastrocne-
mius (GAS) muscle and the oxidative, mixed fast/slow (type II/I)758 Cell Reports 16, 757–768, July 19, 2016soleus (SOL) muscle, respectively (Figures S1A and S1B). The
microarray analysis revealed a cluster of miRNAs differentially
expressed in GAS and SOL muscles (Table S1), including miR-
182, which is highly expressed in GAS muscles. Consistent
with the early reports, we observed that miR-499 and miR-
208b were enriched in SOL muscles (van Rooij et al., 2009;
Zhang et al., 2014a). Some of the results from microarray anal-
ysis were further confirmed by qPCR analysis (Figure 1A). Abso-
lute quantification results showed that miR-182 displayed a
moderate level of expression inmuscle, compared to others (Fig-
ures S1C and S1D). These results suggest that miR-182 is en-
riched in fast-twitch muscle and might be involved in fast-twitch
myofiber development and/or glycolytic metabolism.
miR-182 IsRequired forMaintaining Fast-TwitchMuscle
Phenotype
A miR-182 knockout (KO) mouse model was used to test
whether miR-182 plays a role in myofiber-type determination
(Jin et al., 2009). Genotyping results and qPCR analysis in the
muscle of miR-182 KO mice suggest that miR-182 has been
deleted efficiently (Figures S1E and S1F). The body weights of
KO mice and wild-type (WT) mice were compared over the
development (from 2 to 18 weeks) (Figure S1G). A slight, but sta-
tistically significant, decrease of bodyweight was detected in the
age-matched KO mice older than 10 weeks. The net weights of
slow-twitch SOL muscles, fast-twitch tibialis anterior (TA), and
GAS muscles were measured, respectively. The net weight, as
well as the ratio of TA and GAS muscle weight to body weight,
was significantly decreased in KO mice compared to WT mice
(Figures 1B and 1C). In contrast, no significant difference of the
weight of slow-twitch SOL muscles was detected between KO
and WT mice (Figures S1H and S1I). Consistently, body compo-
sition analysis using nuclear magnetic resonance (NMR) ex-
hibited a lower lean body mass in KO mice compared to WT
mice (Figure 1D). These data imply that miR-182may be involved
in muscle mass maintenance of the fast-twitch glycolytic muscle
but not of the slow-twitch oxidative muscle.
We also observed that the percentile of type I fiber was
increased in both the GAS and SOL muscles of KO mice,
compared toWTmice, by ATPase staining (Figures 1E–1G), sug-
gesting the involvement of miR-182 in muscle fiber-type specifi-
cation. Consistently, miR-182 deficiency led to a fast-to-slow
shift in MyHC expression (Figure 1H). The shift from fast- to
slow-twitch muscle phenotype in mice lacking miR-182 was
further validated by immunostaining analysis (Figures 1I–1K).
We did not observe any changes in the cross-sectional area of
muscle fibers from the SOL and GAS muscles of KO mice
compared toWTmice (Figure S1J). We did not find any alteration
in the mRNA expression of nuclear respiratory factor 1 (NRF1),
which is located close to miR-182 on the chromosome, and its
target gene CPT1b in KO mice, suggesting that NRF1 is not
involved (Figure S1K). These results suggest that miR-182 is
required for maintaining the fast-twitch muscle phenotype.
FoxO1 Is a Target Gene of miR-182 in Skeletal Muscle
FoxO1, a key regulator involved in muscle fiber-type determina-
tion and muscle atrophy, was noticed as a direct target gene of
miR-182 (Guttilla and White, 2009; Kamei et al., 2004; Kitamura
Figure 1. miR-182 Is Required for Maintaining Fast-Twitch Muscle Phenotype
(A) qPCR analysis of miRNA expression in the SOL and GASmuscles of mice (n = 3). Means ± SD are shown. *p < 0.05 versus SOLmuscle; **p < 0.01 versus SOL
muscle; ***p < 0.001 versus SOL muscle.
(B and C) The net weights of fast-twitch TA and GAS muscles (B) and the ratios of TA and GAS muscle weight (MW) to body weight (BW) (C) in WT and KO mice
(n = 5).
(D) Analysis of lean mass of WT and KO mice by NMR technique (n = 13–16).
(E and F) Metachromatic ATPase staining of GAS and SOL muscles of WT and KOmice under different experimental condition as indicated. Scale bars, 150 mm.
(G) Percentage of type I fibers in SOL muscle of WT and KO mice according to the ATPase staining (n = 3).
(H) qPCR analysis of the mRNA expression of MHC isoforms in the GAS muscle of WT and KO mice (n = 3).
(I and J) Immunostaining of the SOL (I) and GAS (J) muscles of WT and KO mice using antibody against myosin-slow (green) and dystrophin (red). Scale bars,
100 mm.
(K) Percentage of myosin-slow fibers in the SOL muscle of WT and KO mice according to the immunostaining (n = 3).
Means ± SD are shown for (B)–(D), (G), (H), and (K). *p < 0.05 versus WT mice; **p < 0.01 versus WT mice.
See also Figure S1.et al., 2007; Stittrich et al., 2010). Whether miR-182 affected
muscle phenotype directly through FoxO1 was investigated.
KO mice had a higher level of FoxO1 protein in both fast-twitch
GAS and slow-twitch SOL muscles, compared to WT mice (Fig-
ure 2A). An elevated level of FoxO1 mRNA was also observed in
the GAS muscles of KO mice (Figure 2B). Loss of miR-182 re-sulted in an increase of FoxO1 transcripts in the primary myo-
tubes from KO and WT mice (Figure 2C). Consistent with the
data in Figure 1E–1K, we observed higher protein levels of
Myh7 (slow fiber marker) and mRNA levels of two slow fiber
markers, myoglobin (MB) and Troponin I Type 1 (Tnni1), in the
muscles or muscle cells from KO mice, compared to WT miceCell Reports 16, 757–768, July 19, 2016 759
Figure 2. FoxO1 Is a Target Gene ofmiR-182
in Skeletal Muscle
(A) Western blot analysis of FoxO1, Myh7, and
Tubulin protein expression in the GAS and SOL
muscles of WT and KO mice.
(B) qPCR analysis of FoxO1, MB, and Tnni1 mRNA
expression in the GAS muscle of WT and KO mice
(n = 3). Means ± SD are shown. **p < 0.01 versus
WT mice.
(C) qPCR analysis of FoxO1, MB, and Tnni1 mRNA
expression in primary myotubes derived from WT
and KO mice (n = 3). Means ± SD are shown. **p <
0.01 versus WT myotubes; ***p < 0.001 versus WT
myotubes.
(D) qPCR analysis of FoxO1 mRNA expression in
C2C12 myotubes transfected with miR-182
mimics. Means ± SD are shown. *p < 0.05 versus
cells transfected with mimics control.
(E) Western blot analysis of FoxO1 protein
expression in C2C12 myotubes 24 or 48 hr after
transfection with miR-182 mimics or mimics
control.
(F) Western blot analysis of FoxO1 protein levels in
the GAS, SOL, and TA muscles of mice.
See also Figure S2.(Figures 2A–2C). In addition, overexpression of miR-182 using
specific mimics reduced both mRNA and protein levels of
FoxO1 in C2C12myotubes (Figures 2D and 2E). Moreover, over-
expression of miR-182 inhibited the luciferase activity of the re-
porter containing the FoxO1-30 UTRwith anmiR-182-responsive
element (MRE) in C2C12 myotubes (Figure S2A). As expected,
we observed the highest mRNA and protein levels of FoxO1 in
slow-twitch SOL muscles, in which the expression of miR-182
was the lowest (Figures 2F, S2B, and S2C). These results sug-
gest that FoxO1 is a target of miR-182 in skeletal muscle and
might be responsible for the atrophy phenotype and the shift
from fast- to slow-twitch myofiber type in themuscle of KOmice.
miR-182 Plays a Regulatory Role in Glucose
Homeostasis
FoxO1 regulates the muscle fuel usage by modulating PDHC ac-
tivity via PDK4 (Furuyama et al., 2003).We speculated that the up-
regulation of FoxO1 due to miR-182 loss would impair metabolic
flexibility and lead to abnormal glucose homeostasis. As ex-
pected, our results revealed that KO mice exhibited impaired
glucose tolerance (Figures 3A and 3B), indicating that miR-182
is required for maintaining normal glucose homeostasis. We
then determined themiR-182 expression pattern in the GASmus-
cles of mice with different blood glucose levels. We found that
miR-182 expression was upregulated in the GAS muscles of
mice fasted overnight, which was accompanied by a drop in
blood glucose level (Figures 3C and S3A). In contrast, the expres-
sion of miR-182 was downregulated in the GAS muscles of mice
after HFD feeding for 2 months, which led to an increase in blood
glucose level (Figures 3D and S3B). Furthermore, in a cohort of
human subjects with normal glucose levels, a moderate negative
correlation (r2 = 0.44, p < 0.0001) between the level of miR-182 in
muscle specimens and the blood glucose level was observed
(Figure 3E), further suggesting an association of miR-182 expres-
sion with the maintenance of glucose homeostasis.760 Cell Reports 16, 757–768, July 19, 2016The effect of glucose and insulin on the expression of miR-182
in C2C12 myotubes was investigated. Interestingly, we found
that decreasing the glucose concentration in the culture medium
induced the expression of miR-182, while insulin treatment
decreased miR-182 levels (Figures 3F and 3G). We then tested
whether FoxO1, as a downstreamgene of insulin signaling, could
affect the expression of miR-182. As expected, overexpression
of FoxO1 stimulated the expression of miR-182, while downre-
gulation of FoxO1 by specific small interfering RNA (siRNA)
repressed the expression of miR-182 in C2C12 myotubes (Fig-
ures S3C and S3D).
PDK4 Is a miR-182 Target in Skeletal Muscle
To test whether the effect of miR-182 on glucose metabolism
was solely dependent on FoxO1, we introduced a FoxO1
expression plasmid lacking 30 UTR into the C2C12 myotubes
transfected with an agomir RNA (agomiRNA) for miR-182 (ago-
miR-182) or a control agomiRNA. Interestingly, we observed
that overexpression of FoxO1 was unable to totally attenuate
the repressive effect of miR-182 on both mRNA and protein
expression of PDK4, suggesting that FoxO1 was not solely
responsible for the effect of miR-182 on PDK4 (Figures 4A and
4B). We identified a putative miR-182 target site in the PDK4-30
UTR, which is highly conserved across different species (Fig-
ure 4C). Overexpression of miR-182 repressed the luciferase
activity of a reporter containing PDK-30 UTR with an miR-182-
responsive element in HEK293T cells and C2C12 myoblasts,
respectively (Figures 4D and S4A). In contrast, overexpression
ofmiR-182 had no repressive effect on a reporter with amutation
in miR-182 responsive element (Figure 4D).
As expected, overexpression of miR-182 decreased both the
mRNA and protein levels of PDK4 in C2C12 myotubes (Figures
4E and 4F), while loss of miR-182 resulted in an elevation in
PDK4 mRNA levels (Figure 4G) and protein levels (Figure 4H) in
the GAS muscles of KO mice compared to WT mice. Similar
Figure 3. miR-182 Plays a Regulatory Role
in Glucose Homeostasis
(A and B) Glucose tolerance test (GTT) (A) and area
under the curve (AUC) data for GTT (B) in WT and
KO mice (n = 5–8). Means ± SD are shown. *p <
0.05 versus WT mice; **p < 0.01 versus WT mice.
(C) qPCR analysis of miR-182 expression in the
GAS muscle of fed and fasted mice (n = 3). Means
± SD are shown. ***p < 0.001 versus fed mice.
(D) qPCR analysis of miR-182 expression in the
GAS muscle of low-fat diet (LFD)- and HFD-fed
mice (n = 3). Means ± SD are shown. **p < 0.01
versus LFD-fed mice.
(E) Correlation between relative miR-182 levels
and blood glucose levels in a group of humans
with normal blood glucose levels (n = 16).
(F) qPCR analysis of miR-182 expression in the
C2C12 myotubes cultured in medium with high-
glucose (High Glu) concentration, low-glucose
(Low Glu) concentration, or without glucose (No Glu). Means ± SD are shown. *p < 0.05 versus control group as indicated.
(G) qPCR analysis of miR-182 expression in the C2C12 myotubes treated with insulin in the presence of high-glucose medium (High Glu) or in the absence of
glucose (No Glu). Means ± SD are shown. **p < 0.01; ***p < 0.001 versus control group as indicated.
See also Figure S3.results were obtained from the GAS muscles of female KO mice
(Figure S4B). Since it is known that the expression of FoxO1 and
PDK4 are elevated upon fasting, it is not surprising to see a larger
upregulation of FoxO1 and PDK4 in the GASmuscles of KOmice
upon fasting (Figure S4C). In addition, both protein and mRNA
levels of PDK4were higher in slow-twitch SOLmuscle than those
in fast-twitch GASmuscle (Figures 4I and 4J). These results indi-
cated that PDK4 is a direct target gene of miR-182 in skeletal
muscle and might mediate the metabolic effect of miR-182.
miR-182 Modulates Glucose Utilization in Skeletal
Muscle
Since the PDHC activity largely depends on its phosphorylation
status by PDK isoenzymes, we speculated that miR-182 could
affect the phosphorylation status of PDHC. To test this hypothe-
sis, we investigated the effect of miR-182 on the phosphorylation
status of PDHC. As expected, overexpression of miR-182
decreased the protein levels of FoxO1, PDK4, and the phosphor-
ylated alpha subunit of pyruvate dehydrogenase (p-PDHA1),
while inhibition of miR-182 increased the protein levels of
FoxO1, PDK4, and p-PDHA1 in C2C12 myotubes (Figure 5A)
and L6 myotubes (Figure S5A). In KO mice, an increase in
p-PDHA1 protein levels was observed in GAS muscles (Fig-
ure 5B). Importantly, we found that overexpression of miR-182
by using agomiR-182 rescued the phenotype of increased
FoxO1, PDK4, and p-PDHA1 levels in primary myotubes from
KO mice, suggesting that the altered expression of FoxO1,
PDK4, and p-PDHA1 is as a direct effect of de-repression via
miR-182 (Figure 5C).
We then analyzed the enzyme activity of PDHC in the GAS
muscles of KO mice and C2C12 myotubes transfected with an
antagomir specific for miR-182 (Ant-182) or agomiR-182. As ex-
pected, bothmiR-182 deficiency in KOmice and downregulation
of miR-182 in C2C12myotubes resulted in a lower enzyme activ-
ity of PDHC compared to control groups, while overexpression
of miR-182 in C2C12 myotubes led to a higher activity (Fig-ure 5D). Since PDHC catalyzes the key step in glucose oxidation,
we measured the glucose oxidation by using [U-14C] D-glucose.
As expected, either lacking miR-182 or inhibition of miR-182 by
Ant-182 suppressed the glucose oxidation, while overexpres-
sion of miR-182 by agomiR-182 transfection enhanced the
glucose oxidation inmyocytes (Figure 5E). These results suggest
that miR-182 modulates glucose oxidation through regulating
PDHC via PDK4.
We also performed in vivo indirect calorimetry to measure the
fuel utilization in KOmice. Consistent with the inhibition of PDHC
and decreased glucose oxidation in muscle cells, KO mice dis-
played a lower respiratory exchange ratio (RER), suggesting
that carbohydrate utilization was reduced (Figure 5F). In agree-
ment of these findings, we found that pyruvate was accumulated
when miR-182 was lacking or inhibited, while pyruvate content
was reduced after miR-182 overexpression in myotubes (Fig-
ure 5G). The observation that acetyl-CoA levels were elevated
in C2C12 myotubes overexpressing miR-182 was consistent
with the increased enzyme activity of PDHC (Figure S5B). In
contrast, acetyl-CoA levels were also elevated in myotubes lack-
ing miR-182 or treated with Ant-182, indicating that the usage of
other energy sources might be increased to compensate the
defect in glucose utilization due to the inhibition of PDHC (Fig-
ure S5B). This result was consistent with the indirect calorimetry
data from KO mice, further suggesting that miR-182 modulates
fuel selection.
Interestingly, qPCR analysis revealed that agomiR-182 treat-
ment restored the MyHC expression, suggesting that the effect
of miR-182 on muscle fiber-type conversion is direct (Figure 5H).
The role of miR-182 in regulating muscle glycolytic phenotype
and metabolism was further investigated by measuring glycol-
ysis and basal respiration. Both the glycolysis capacity and the
rate of glycolysis were inhibited by Ant-182 transfection in
C2C12 myotubes (Figures 5I and S5C). The opposite results
were obtained in C2C12 myotubes transfected with agomiR-
182, although the change in the rate of glycolysis did not reachCell Reports 16, 757–768, July 19, 2016 761
Figure 4. PDK4 Is a miR-182 Target in Muscle
(A) qPCR analysis of FoxO1 and PDK4 mRNA expression in C2C12 myotubes transfected with agomiR-182 mimics and/or FoxO1 expression vector lacking 30
UTR (n = 3). Means ± SD are shown. *p < 0.05; **p < 0.01; ***p < 0.001; NS, not significant.
(B) Western blot analysis of FoxO1, PDK4, and GAPDH protein expression in C2C12 myotubes transfected with agomiR-182 and/or FoxO1 expression vector
lacking 30 UTR.
(C) Sequence alignment of miR-182 and the PDK4 30 UTR from various species.
(D) Analysis of the effect of miR-182 mimics on the activity of the reporter containing PDK4 30UTR or PDK4 30 UTR mutated at the miR-182 regulatory element
(MRE mutant) by luciferase assay in C2C12 myoblasts (n = 3). Means ± SD are shown. **p < 0.01 versus cells transfected with mimics control. RLU, relative light
units.
(E) qPCR analysis of PDK4 mRNA expression in C2C12 myotubes transfected with increasing amounts of miR-182 mimics (4 nM and 10 nM; n = 3). Means ± SD
are shown. **p < 0.01 versus cells transfected with mimics control; ***p < 0.001 versus cells transfected with mimics control.
(F) Western blot analysis of PDK4 protein expression in C2C12 myotubes 24 or 48 hr after transfection with miR-182 mimics or mimics control (n = 3).
(G) qPCR analysis of FoxO1, PDK4, and PGC-1amRNA expression in the GAS muscle of WT and KO mice (n = 3). Means ± SD are shown. *p < 0.05 versus WT
mice; **p < 0.01 versus WT mice.
(H) Western blot analysis of FoxO1, PDK4, and Tubulin protein expression in the GAS muscle of WT and KO mice (n = 4).
(I) Western blot analysis of FoxO1, PDK4, and Tubulin protein expression in the GAS and SOL muscles of mice (n = 3).
(J) qPCR analysis of FoxO1, PDK4, and PGC-1a mRNA expression in the GAS and SOL muscles of mice (n = 3). Means ± SD are shown. *p < 0.05 versus SOL
muscle; **p < 0.01 versus SOL muscle.
See also Figure S4.statistical significance (Figures 5I and S5C). Consistent with
the role of miR-182 in promoting a glycolytic metabolic pheno-
type, the basal respiration was increased after Ant-182 treat-
ment, while it was decreased after agomiR-182 transfection
(Figure 5J).
Although the aforementioned in vitro results demonstrated
that miR-182 modulates glucose oxidation in skeletal muscle in
a cell-autonomous manner, we could not totally rule out the pos-
sibility that the effect of miR-182 in other metabolic tissues also
contributed to the phenotype observed in miR-182 whole-body
KO mice used in this study. We then tested whether FoxO1
and PDK4 were affected in the liver and adipose tissue of KO
mice. Interestingly, only PDK4 protein expression was altered762 Cell Reports 16, 757–768, July 19, 2016in the adipose tissue of KO mice (Figures S5D–S5G), suggesting
that the elevation of PDK4 in adipose tissues might also
contribute to the altered fuel usage in KO mice. The elevation
of PDK4 in adipose tissuesmight also contribute to the increased
fat mass observed in KO mice (Figure S5H), since PDK4 could
redirect glucose from oxidation toward triglyceride synthesis
(Barquissau et al., 2016). In addition, we did not observe any
changes in liver triglyceride level in KO mice (Figure S5I).
A recent study reported that in vivo ablation of mesodermal
transcription factor T-box 15 (Tbx15), which is highly and specif-
ically expressed in glycolytic myofibers, led to a decrease in
muscle size and glycolytic fibers and an increase in oxidative fi-
bers, adiposity, and glucose intolerance (Lee et al., 2015). Since
Figure 5. miR-182 Modulates Glucose Utilization in Muscle
(A) Western blot analysis of FoxO1, PDK4, p-PDHA1, t-PDHA1, b-actin, and GAPDH protein levels in C2C12 myotubes transfected with miR-182 mimics or miR-
182 inhibitor as indicated.
(B) Western blot analysis of FoxO1, PDK4, p-PDHA1, t-PDHA1, and GAPDH protein levels in the GASmuscle of WT and KOmice (n = 4–5). Relative protein levels
of FoxO1 and PDK4, and p-PDHA1 were normalized to those of GAPDH and t-PDHA1, respectively. Means ± SD are shown. **p < 0.01. The band corresponding
to FoxO1 is indicated by the arrow.
(C) Western blot analysis of FoxO1, PDK4, p-PDHA1, t-PDHA1, and GAPDH protein expression in primary myotubes derived fromWT and KO mice, which were
transfected with agomiR-182 as indicated.
(legend continued on next page)
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some of the phenotypes we found in the muscle, liver, and adi-
pose tissue of KO mice were similar to those in Tbx15 knockout
mice, we tested whether Tbx15 could mediate the effect of miR-
182. However, we did not detect any changes in themRNA levels
of Tbx15 (Figure S5J), suggesting that Tbx15 might not be
involved in the phenotypic alteration in KO mice.
TNFa Reduces miR-182 Levels Shortly after HFD
Feeding
Since tumor necrosis factor a (TNFa) level is increased in dia-
betic mice (Borst and Conover, 2005), we tested whether it
was one of the signals regulating miR-182 expression in the
HFD-induced diabetic mouse model. We found that TNFa
reduced miR-182 levels in a dose-dependent manner in C2C12
myotubes, which was accompanied by an increase in both
FoxO1 and PDK4 mRNA transcripts (Figure 6A; Figure S6A).
Our in vivo study also showed that, in the GAS muscles of
mice after HFD feeding for 2 months, an upregulation of TNFa
(Figure 6B), FoxO1, and PDK4 (Figure 6C) and a downregulation
of miR-182 (Figure 3D) were observed. These results indicate
that the increased levels of TNFa in the muscle of HFD-fed
mice might contribute to the downregulation of miR-182 and
the upregulation of FoxO1 and PDK4. To exclude the possibility
that the change of muscle fiber-type composition—but not the
elevated levels of TNFa, due to the long-term HFD feeding
(2 months)—altered the expression of miR-182/FoxO1/PDK4,
short-term HFD feeding for 1 and 2 weeks was performed, which
did not cause amyofiber-type switch (Figure S6B).We found that
1-week HFD feeding was able to significantly change the levels
of TNFa and miR-182 (Figures 6D and 6E), the mRNA levels of
FoxO1 and PDK4, and the protein levels of FoxO1 (Figures 6F,
6G, and S6C) in GAS muscles. The increase in the protein levels
of PDK4 and p-PDHA1 reached statistical significance in the
GAS muscles of mice after 2 weeks of HFD feeding (Figures
6G and S6C). These data indicate that the dysregulation of the
miR-182/FoxO1/PDK4 axis due to the elevated levels of TNFa
contributes to metabolic inflexibility at a very early stage of
HFD feeding and might be involved in disease initiation.
Overexpression of miR-182 Improves Glucose
Metabolism
To test whether miR-182 could serve as a therapeutic target for
metabolic diseases, HFD-fed mice were treated with agomiR-(D) Total PDHA activities were determined in the skeletal muscle (GAS) from WT o
agomiR-182 by using a PDH activity microplate assay kit and were normalized to
shown. *p < 0.05; **p < 0.01.
(E) Relative levels of glucose oxidation were measured in primary myotubes deriv
with Ant-182 or agomiR-182 for 48 hr. Means ± SD are shown. *p < 0.05; **p < 0
(F) Respiratory exchange ratios (RERs) were analyzed by performing indirect ca
production to oxygen consumption. Means ± SD are shown. *p < 0.05.
(G) Relative levels of pyruvate were examined in primary myotubes derived from
transfected with Ant-182 or agomiR-182 for 48 hr. Means ± SD are shown. *p <
(H) qPCR analysis of the mRNA expression of MHC isoforms in primary myotu
transfected with agomiR-182 as indicated. Means ± SD are shown. *p < 0.05; **
(I and J) Glycolysis capacity (I) and basal respiration (J) were analyzed in the C2C12
acidification rate (ECAR) and the oxygen consumption rate (OCR) measuremen
*p < 0.05; **p < 0.01.
See also Figure S5.
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182 treatment was confirmed in the muscle of HFD-fed mice
(Figure S6D). Interestingly, agomiR-182 treatment improved
glucose tolerance in these diabetic mice without changing the
body weight gain (Figures 6H and S6E). These agomiR-182-
treated mice also displayed a smaller increase in fasting glucose
level upon the HFD feeding compared to control mice (Figure 6I).
As expected, the downregulation of FoxO1 and PDK4 and
reduction of PDHA1 phosphorylation were observed in the mus-
cle of mice treated with agomiR-182 (Figures 6J and 6K). A slow-
to-fast shift in MHC expression upon agomiR-182 treatment was
also detected (Figure 6L), suggesting that restoration of miR-182
in the HFD-fedmice triggers an oxidative-to-glycolytic metabolic
shift in muscle, which is able to improve glucose metabolism. To
be noted, we did not detect any changes in the mRNA expres-
sion of miR-182 and its target genes in the liver of HFD-fed
mice treated with agomiR-182 (Figure S6F). The beneficial effect
of agomiR-182 treatment on glucose metabolism was also seen
in ob/ob mice (Figures S6G–S6I).
FoxO1 and miR-182 Form a Feedback Loop under
Different Nutritional Status
The finding that both of the levels of miR-182 and its target genes
(FoxO1/PDK4) increased (Figures 3C and S4C) in the muscle of
mice upon fasting prompted us to determine the levels of miR-
182 and FoxO1/PDK4 under different feeding conditions. Inter-
estingly, we found that both mRNA and protein levels of either
FoxO1 or PDK4 were increased in the GASmuscles of mice after
an overnight fast and then decreased upon refeeding (Figures
7A–7C), which shared a similar expression pattern with miR-
182 (Figure 7D). Given that FoxO1 is a positive regulator of
miR-182 (Figures S3C and S3D), we propose that FoxO1 and
miR-182 form a feedback loop and maintain glucose homeosta-
sis under different nutritional status.
Taken together, our data indicate that skeletal muscle miR-
182 regulates glucose homeostasis through controlling the activ-
ity of PDHC via targeting FoxO1/PDK4 in a cell-autonomous
manner (Figure 7E). Under different feeding conditions, FoxO1
and miR-182 form a feedback loop and confer robust and pre-
cise controls on fuel usage and glucose metabolism (Figure 7F).
Upon HFD feeding, downregulation of miR-182 by TNFa might
contribute to aberrant fuel selection and metabolic inflexibility
(Figure 7G).r KO mice (n = 5) or in the C2C12 myotubes (n = 3) transfected with Ant-182 or
total protein. DmOD450, milli-optical density units at 450 nm. Means ± SD are
ed from WT or KO mice (n = 3–4) or in the C2C12 myotubes (n = 3) transfected
.01.
lorimetry using WT and KO mice (n = 4). VCO2/VO2, ratio of carbon dioxide
the GAS muscles of WT or KO mice (n = 3) or in the C2C12 myotubes (n = 3)
0.05; **p < 0.01.
bes derived from the GAS muscles of WT and KO mice (n = 3), which were
p < 0.01.
myotubes (n = 3–5) transfected with Ant-182 or agomiR-182. The extracellular
ts were performed using a Seahorse XF instrument. Means ± SD are shown.
Figure 6. Restoration of miR-182 Expression Improves Glucose Metabolism in HFD-Fed Mice
(A) qPCR analysis ofmiR-182, FoxO1, and PDK4mRNA levels in C2C12myotubes treatedwith TNFa (n = 4). Means ±SD are shown. *p < 0.05 versus cells treated
with vehicle (control); **p < 0.01 versus control.
(B and C) qPCR analysis of TNFa (B), FoxO1, and PDK4 (C) mRNA expression in the GAS muscle of mice after HFD feeding for 2 months (n = 3). Means ± SD are
shown. *p < 0.05 versus LFD-fed mice; ***p < 0.001 versus LFD-fed mice.
(D–F) qPCR analysis of TNFa (D), miR-182 (E), FoxO1, and PDK4 (F) expression levels in the GAS muscle of mice after 1 or 2 weeks of HFD feeding (HFD-1w or
HFD-2w) (n = 6). Means ± SD are shown. *p < 0.05 versus mice fed with regular chow diet (Control); **p < 0.01 versus control.
(G) Western blot analysis of FoxO1, PDK4, p-PDHA1, t-PDHA1, and GAPDH protein levels in GASmuscle of mice fed with HFD for 1 or 2 weeks (HFD-1w or HFD-
2w) (n = 3).
(H) Glucose tolerance test (GTT) (left) and area under the curve (AUC) data for GTT (right) in HFD-fedmice treatedwith agomiR-182 (n = 4). Means ±SD are shown.
*p < 0.05.
(I) Increase in blood glucose levels in HFD-fed mice after agomiR-182 treatment (n = 8). Means ± SD are shown. *p < 0.05.
(J) qPCR analysis of miR-182, FoxO1, and PDK4 in GAS muscle of HFD-fed mice treated with agomiR-182 (n = 3). Means ± SD are shown. *p < 0.05; **p < 0.01.
(K) Western blot analysis of FoxO1, PDK4, p-PDHA1, t-PDHA1, and GAPDH protein levels in GAS muscle of HFD-fed mice treated with agomiR-182.
(L) qPCR analysis of the mRNA expression of MHC isoforms in GAS muscle of HFD-fed mice treated with agomiR-182 (n = 3). Means ± SD are shown. *p < 0.05;
**p < 0.01 versus HFD-fed mice treated with agomiRNA control.
See also Figure S6.DISCUSSION
During feeding and fasting cycles, carbohydrates and fatty acids
are the two primary substrates in oxidative metabolism. Meta-
bolic flexibility, which coordinates the glucose/fat oxidation
switch to homeostatic signals, is essential for maintaining meta-
bolic homeostasis (Galgani et al., 2008). The loss of metabolic
flexibility responding to energy demands and nutrient availabilityleads to metabolic disease. Fuel partitioning is mainly controlled
by the PDHC activity, which is suppressed by PDK4 through
phosphorylation (Patel and Korotchkina, 2006). Therefore,
inappropriate suppression of PDHC activity in skeletal muscle
promotes the development of hyperglycemia by fueling exces-
sive gluconeogenesis. However, whether and how miRNAs
are involved in the substrate selection for oxidation is largely
unknown. Here, we report an important role for miR-182 inCell Reports 16, 757–768, July 19, 2016 765
Figure 7. Working Hypothesis for the Regulation of Glucose Utilization by miR-182
(A and B) qPCR analysis of FoxO1 (A) and PDK4 (B) mRNA expression in the GASmuscle of fed, fasted, and refed mice (n = 3). Means ± SD are shown. *p < 0.05;
**p < 0.01.
(C) Western blot analysis of FoxO1, PDK4, and GAPDH protein levels in GAS muscle of fed, fasted, and refed mice (n = 3).
(D) qPCR analysis of miR-182 expression in the GAS muscle of fed, fasted, and refed mice (n = 3). Means ± SD are shown. **p < 0.01; NS, not significant.
(E) Schematic diagram of the working model of skeletal muscle miR-182.
(F) Schematic diagram of the FoxO1-miR-182 feedback loop in maintaining glucose homeostasis under different nutritional status.
(G) Schematic diagram of the miR-182-mediated metabolic inflexibility upon HFD feeding.regulating fuel usage through the FoxO1/PDK4/PDHC axis in
skeletal muscle. Our data suggest that miR-182 could be a ther-
apeutic target for improving glycemic control for patients with
diabetes.
The PDK4 gene, as a major direct target of FoxO1, is
frequently altered in a variety of diseases. For example, PDK re-
mains in the ‘‘starvation’’ mode and keeps a high level in skeletal
muscles during obesity development, even though plentiful nu-
trients are available (Frier et al., 2011). mRNA transcripts of
PDK4 were upregulated in the muscle of T2D patients compared
to the healthy subjects after overnight fasting (Kulkarni et al.,
2012). Besides that, the methylation status of PDK4 promoter
was reduced in T2D patients, suggesting that epigenetic modifi-
cation is also involved in the T2D pathogenesis (Kulkarni et al.,
2012). In this study, our finding that downregulation of miR-182
in HFD-fed mice was accompanied with an increased PDK4
expression suggests a miRNA-basedmechanism for HFD-asso-
ciated hyperglycemia.
miRNAs, together with transcription factors, form a compli-
cated and highly interconnected network to mediate biological
processes. Since miRNA processing is faster than protein trans-
lation, miRNAs are ideally suited to serve in loops that confer
robustness and precision (Ebert and Sharp, 2012). In this study,766 Cell Reports 16, 757–768, July 19, 2016we demonstrated that FoxO1 and miR-182 formed a feedback
loop to regulate the PDHC activity under different feeding condi-
tions. Upon fasting, the starvation signal directly stimulates the
expression of FoxO1 and PDK4 but, at the same time, promotes
inhibition at a post-transcriptional level by inducing miR-182
expression (Figure 7F). Thus, miR-182 acts as a sensor of energy
stress and can confer cell-exquisite temporal and quantitative
precision over cell signaling. In this way, miR-182 serves as a
guard to avoid overactivation of PDK4 and excessive inhibition
of PDHC activity, thereby allowing accurate tuning of glucose
homeostasis.
Since the dietary-induced impairment of PDHC activation in
skeletal muscles is one of the causative factors for insulin resis-
tance and other metabolic syndromes (Gorter et al., 2004), inhib-
itors targeting FoxO1/PDK4 or agents to restore miR-182 will
improve the glucose metabolism in patients. We have shown
that administration of agomiR-182 could suppress the expres-
sion of FoxO1/PDK4, reduce the phosphorylation of PDHC in
themuscle of mice under HFD feeding, and eventually derepress
the glycolytic program and alleviate the metabolic inflexibility in
these mice, as shown by improved glucose metabolism. Our
data not only reinforce the concept that modulation of PDK4
expression could have significant beneficial effects on nutrient
handling in obesity but also support the notion that the oxidative-
to-glycolytic metabolic shift in skeletal muscle is beneficial and
could alleviate metabolic inflexibility.
Our in vitro results demonstrated that miR-182 modulates
glucose oxidation in skeletal muscle in a cell-autonomous
manner. However, we could not rule out the possibility that the
role of miR-182 in other metabolic tissues might also contribute
to the dysregulation of glucose metabolism in KO mice. Given
that skeletal muscle accounts for 90% of insulin-stimulated
glucose uptake, adipose tissue accounts for only 10%, glucose
is stored as glycogen in skeletal muscle, and fatty acids are
stored as triglyceride in adipose tissue, it is likely that the
impaired glucose homeostasis observed in miR-182 KO mice
was mainly due to the defects in muscle. In addition, we only
observed the changes in the protein levels of PDK4 in the
adipose tissue of KO mice. Moreover, the protein levels of
p-PDHA1 did not change significantly in the adipose tissue of
KO mice (Figures S5D–S5G). These findings further suggest
that the metabolic phenotype observed in KO mice was due to
the abnormal glucose ultilization caused by miR-182 deficiency.
FoxO3, another member of the forkhead box O family, is also
known to play an important role in muscle atrophy and auto-
phagy (Mammucari et al., 2007; Zhao et al., 2007). Recently,
miR-182 has been shown to control FoxO3 levels and correlated
with glucocorticoid-induced autophagy genes (Hudson et al.,
2014). Therefore, it is possible that the dysregulation of FoxO3
due to miR-182 deficiency might also contribute to the muscle
loss in KO mice. Further study is required to determine whether
autophagy was involved in the muscle atrophy in KO mice.
Disease isoften the result ofanaberrantor inadequate response
to physiologic and pathophysiologic stress (Mendell and Olson,
2012).miRNAsoftenprofoundly influence the responsesof tissues
to physiologic and pathophysiologic stress (Leung and Sharp,
2010). In this study, we demonstrate that FoxO1 and miR-182
form a feedback loop to control fuel usage and maintain glucose
homeostasis, establishingmiR-182 asa critical regulator that con-
fers robustness and precision on the regulation of fuel usage and
glucose homeostasis. Our data suggest that HFD-induced down-
regulation of miR-182 contributes to the upregulation of FoxO1/
PDK4, which leads tometabolic inflexibility and abnormal glucose
homeostasis, while restoration of miR-182 expression is able to
alleviate metabolic inflexibility and improves glucose metabolism
in HFD-fed mice. Our studies reinforce the notion that promoting
a metabolic shift toward a faster and more glycolytic phenotype
is beneficial in diabetes and, thus, constitutes a promising
approach to combat metabolic disease.EXPERIMENTAL PROCEDURES
See the Supplemental Experimental Procedures for additional details.
In Vivo Study
8- to 12-week-old male mice were used in this study. All experimental proce-
dures and protocols were reviewed and approved by the Institutional Review
Board of the Institute for Nutritional Sciences, Shanghai Institutes for Biolog-
ical Sciences, Chinese Academy of Sciences (permit number: 2011-AN-14).
miR-182 KO, ob/ob, and wild-type mice were maintained as described previ-
ously (Liu et al., 2014). Muscle weight was measured using a NMR Analyzer
(Bruker). The human muscle specimens of quadriceps were obtained duringsurgery from patients receiving total hip replacement at the Department of Or-
thopedics, Zhongshan Hospital. All the procedures were reviewed and
approved by the Ethics Committee of Zhongshan Hospital, Fudan University,
and informed consent was obtained from all patients. A detailed description for
the glucose-tolerance test, HFD feeding, chemically modified miRNA oligonu-
cleotide treatment, in vivo indirect calorimetry measurement, and tissue
collection can be found in the Supplemental Experimental Procedures.
Cell Culture and Transfection
A detailed description of the primary myoblast isolation, the culture and differ-
entiation of C2C12 and L6 myoblasts, transfection using Lipofectamine 2000
(Invitrogen), insulin and TNFa treatment, luciferase assays, and the plasmids
and RNA oligonucleotide used in this study can be found in the Supplemental
Experimental Procedures.
PCR and Western Blot Analysis
See the Supplemental Experimental Procedures for detail information.
Phenotype Characterization and Metabolic Profiling
A detailed description of the immunostaining and metabolic ATPase staining;
the measurement of the muscle cross-sectional area; glucose oxidation,
oxygen consumption, and glycolysis; PDH (pyruvate dehydrogenase) enzyme
activity; and pyruvate, acetyl-CoA, and triglyceride can be found in the Supple-
mental Experimental Procedures.
Statistical Analysis
GraphPad Prism 5.0 software was applied to all statistical analyses. Data were
presented asmeans ±SD. Student’s t test was performed to assess themeans
of two groups are statistically significant from each other (p < 0.05).
ACCESSION NUMBERS
The accession number for the miRNA data reported in this study is GEO:
GSE81976.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.06.040.
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